supplementary files for study entitled "Systematic review and meta-analysis of the efficacy and risk of adverse events of dupilumab in the treatment of prurigo nodularis"

Published: 16 May 2025| Version 2 | DOI: 10.17632/tnd5kkzhxt.2
Contributors:
Hicham Titou, younes Elkhachine

Description

• Real-world data reveal that dupilumab therapy for prurigo nodularis is effective and well tolerated in the short term, but ophthalmic adverse events frequently occur. • Clinical trials demonstrated that dupilumab is effective and safe for the treatment of prurigo nodularis in adults.

Files

Institutions

  • Universite Cadi Ayyad

Categories

Dermatology

Licence